1Wk·

Lilly and Hims & Hers Partner to Expand Access to FDA-Approved Obesity Drugs Zepbound and Foundayo

$LLY (-1.58%)
$HIMS (-4.92%)

⠀

• Pricing: Foundayo starts at $149/month and Zepbound at $299/month, at the same self-pay prices available to other patients.

• Access: Eligible patients can receive consultations, prescriptions and home delivery directly through the Hims & Hers platform.

• Agreement: Hims & Hers commits not to offer compounded copies of Lilly's GLP-1 drugs, while preserving independent prescribing decisions.

9
1 Comment

Was coming a while, good the news is out now. Now the rest of the peptides, cant wait for the earnings on monday!
•
1
•
Join the conversation